The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month that mold exposure in a rented apartment caused Parkinson's disease in a ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Aug. 19, 2024 — Two new studies are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Parkinson's is a brain condition which is responsible for uncontrolled movements. It causes difficulty in talking, walking, ...

Skin-swab test coming? Another perennial problem in Parkinson’s disease is the difficulty in getting a diagnosis in the early stages of the disease when the characteristic movement symptoms are ...

Attention deficit hyperactivity disorder (ADHD) and Parkinson’s disease are distinct neurological conditions. They typically onset at different life stages: ADHD in childhood and Parkinson’s ...

USE ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD). It is not known if ONAPGO is safe and effective in children.